APA

Schostak M., de Geeter P., Decker T., Resch A., Quiering C. & Schmitz S. (20210128). A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ). : Urologia internationalis.

Chicago

Schostak Martin, de Geeter Patrick, Decker Thomas, Resch Anna, Quiering Claudia and Schmitz Stephan. 20210128. A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ). : Urologia internationalis.

Harvard

Schostak M., de Geeter P., Decker T., Resch A., Quiering C. and Schmitz S. (20210128). A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ). : Urologia internationalis.

MLA

Schostak Martin, de Geeter Patrick, Decker Thomas, Resch Anna, Quiering Claudia and Schmitz Stephan. A Phase 4 Study of Everolimus to Evaluate Efficacy and Safety in Patients with Metastatic Renal-Cell Carcinoma after Failure of First-Line Sunitinib or Pazopanib (SUNPAZ). : Urologia internationalis. 20210128.